Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Celularity Inc (NASDAQ: CELU) closed at $2.01 down -29.47% from its previous closing price of $2.85. In other words, the price has decreased by -$29.47 from its previous closing price. On the day, 1.74 million shares were traded. CELU stock price reached its highest trading level at $2.934 during the session, while it also had its lowest trading level at $1.55.
Ratios:
For a deeper understanding of Celularity Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.22 and its Current Ratio is at 0.26. In the meantime, Its Debt-to-Equity ratio is 2.42 whereas as Long-Term Debt/Eq ratio is at 0.95.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on January 30, 2023, Downgraded its rating to Underweight and sets its target price to $1 from $5 previously.
On June 22, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.H.C. Wainwright initiated its Buy rating on June 22, 2022, with a $15 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 12 ’24 when Lim Kok Thay bought 21,410,983 shares for $0.25 per share. The transaction valued at 5,331,335 led to the insider holds 51,473,762 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CELU now has a Market Capitalization of 44230852 and an Enterprise Value of 111077072. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.73 while its Price-to-Book (P/B) ratio in mrq is 1.59. Its current Enterprise Value per Revenue stands at 2.602 whereas that against EBITDA is -3.094.
Stock Price History:
The Beta on a monthly basis for CELU is 0.79, which has changed by 0.3380282 over the last 52 weeks, in comparison to a change of 0.31827796 over the same period for the S&P500. Over the past 52 weeks, CELU has reached a high of $7.97, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is -21.11%, while the 200-Day Moving Average is calculated to be -39.35%.
Shares Statistics:
For the past three months, CELU has traded an average of 997.24K shares per day and 721530 over the past ten days. A total of 19.38M shares are outstanding, with a floating share count of 10.76M. Insiders hold about 51.12% of the company’s shares, while institutions hold 11.33% stake in the company. Shares short for CELU as of 1731628800 were 934457 with a Short Ratio of 0.94, compared to 1728950400 on 680541. Therefore, it implies a Short% of Shares Outstanding of 934457 and a Short% of Float of 25.129997999999997.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
